1. |
Yacubian EM. Juvenile myoclonic epilepsy: Challengeson its 60th anniversary. Seizure, 2017, 44: 48.
|
2. |
王凤楼. 正确评估脑电图对提高青少年肌阵挛癫痫诊断的价值. 中华神经科, 2009, 42(7): 468-470.
|
3. |
Iris U, Laura Z, Manuela P, et al. Risky decision making in juvenle myoclonic epilepsy. Frontiers in Neurology, 2018, 9: 195.
|
4. |
Machado RA, Garcíaa VF, Astencio AG, et al. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospectinve, unblinded randomize controlled trial. Seizure, 2013, 22(10): 846-855.
|
5. |
赵新春, 邢效如, 台立稳. 拉莫三嗪对癫痫患者疗效和安全性及生活质量影响研究. 现代预防医学, 2015, 42(14): 2663-2665.
|
6. |
Marsan E, Ishida S, Schramm A, et al. DEPDC5 knockout rat: a novel model of mTOR opathy. Neurobiol Dis, 2016, 89: 180-189.
|
7. |
Picard F, Makrythanasis P, Navarro V, et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology, 2014, 82(23): 2101-2106.
|
8. |
欧阳梅. DEPDC5 基因突变的遗传性局灶性癫痫的临床研究. 癫痫杂志, 2018, 4(3): 192-200.
|
9. |
Shen K, Huang RK, Brignole EJ, et al. Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes. Nature, 2018, 556(7699): 64-69.
|
10. |
梅道启, 符娜, 秦炯. 结节性硬化症 TSC1、TSC2 基因型与临床表型研究进展. 中华实用儿科杂志, 2019, 34(4): 309-314.
|
11. |
陈丽卿, 刘艳. DEPDC5 基因突变相关婴儿痉挛症 3 例报告及文献复习. 临床儿科杂志, 2019, 9(37): 669-672.
|
12. |
Lal D, Reinthaler EM, Schubert J, et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol, 2014, 75(5): 788-792.
|
13. |
Scheffer IE, Heron SE, Regan BM, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol, 2014, 75(5): 782-787.
|